EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Histopathological evaluation of facial melasma treated with oral tranexamic acid alone and in combination with ketotifen

Ana Clara Ladeira Cruz, Daniel Pinho Cassiano, Hélio Amante Miot, Ana Cláudia Cavalcante Espósito, Karime Hassum, Mackerley Bleixuvehl de Brito, Milvia Maria Simões E Silva Enokihara, Maria Carolina Cavalcanti Lima Constantino, Heitor Raia Bottura, Joaquim Soares de Almeida, Ediléia Bagatin

Anais Brasileiros de Dermatologia · 2026-05 · 101 (3) · 501336

DOI: 10.1016/j.abd.2026.501336 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Anais Brasileiros de Dermatologia, 2026-05. Verfasst von Ana Clara Ladeira Cruz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Universidade Federal de São Paulo, São Paulo, SP, Brazil. Electronic address: acdermatologiaclinica@gmail.com. Hauptthemen laut MEDLINE: Tranexamic Acid, Ketotifen, Melanosis, Facial Dermatoses. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tranexamic Acid (TA) has demonstrated effectiveness on melasma treatment, and Ketotifen (KET) may inhibit mast cell-mediated melanogenesis. The histologic basis of their depigmenting effects remains unclear.

Objectives

To evaluate histopathological changes from TA with KET over a 3-month treatment.

Methods

In this randomized, double-blind trial, 50 women with facial melasma were assigned to KET 1 mg plus TA 250 mg (TA/KET group) or TA 250 mg (TA group), every 12 h for 3-months, with broad-spectrum sunscreen. Skin biopsies were performed at baseline and day-90. Pri-mary outcome was epidermal melanin density reduction; secondary outcomes included stratum corneum compaction, solar elastosis, basement membrane disruptions, and counts of mast cells, melanocytes (including pendulum melanocytes), and upper dermal VEGF density.

Results

Groups were comparable at baseline. Both showed reduced epidermal melanin without intergroup difference, with unchanged VEGF expression, mast cell and melanocyte count, and stratum corneum parameters. The TA/KET-group presented an increase in epidermal thickness, reduction in solar elastosis, pendulum melanocytes counting, and basal membrane disruptions. Study limitations: The short treatment and follow-up may have limited detection of histologic progression. Toluidine blue, while effective in detecting abundant mast cell populations, may lack sensitivity for precise quantification. PAS staining of the basement membrane may occa-sionally produce artifactual discontinuities, even when the membrane is structurally intact. Ketotifen was not tested alone.

Conclusion

Both interventions led to epidermal melanin reduction. The combination TA/KET induced greater dermal and epidermal remodeling changes that surpassed those with TA alone, showing features associated with photoaging reversal and skin homeostasis restoration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidKetotifenMelanosisFacial DermatosesHumansFemaleDouble-Blind MethodAdultTreatment OutcomeBiopsyDrug Therapy, CombinationMiddle AgedAdministration, OralTime FactorsMelaninsMelanocytesEpidermisFace

Stichwörter der Autor:innen

HistologyKetotifenMelanosisTranexamic acid

Substanzen

Tranexamic AcidKetotifenMelanins

Autor:innen und Institutionen

  • Department of Dermatology, Universidade Federal de São Paulo, São Paulo, SP, Brazil. Electronic address: acdermatologiaclinica@gmail.com.
  • Department of Dermatology, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  • Department of Infectology, Dermatology, Imaging Diagnosis and Radiotherapy, Faculdade de Medicina, Universidade Estadual Paulista, Botucatu, SP, Brazil.
  • Department of Infectology, Dermatology, Imaging Diagnosis and Radiotherapy, Faculdade de Medicina, Universidade Estadual Paulista, Botucatu, SP, Brazil; Service of Dermatology, Universidade do Oeste Paulista, Presidente…
  • Department of Histopathology, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

Zitieren

APA

Cruz, A. C. L., Cassiano, D. P., Miot, H. A., Espósito, A. C. C., Hassum, K., de Brito, M. B., E Silva Enokihara, M. M. S., Lima Constantino, M. C. C., Bottura, H. R., de Almeida, J. S., & Bagatin, E. (2026). Histopathological evaluation of facial melasma treated with oral tranexamic acid alone and in combination with ketotifen. Anais Brasileiros de Dermatologia, 101(3), 501336. https://doi.org/10.1016/j.abd.2026.501336

Vancouver

Cruz ACL, Cassiano DP, Miot HA, Espósito ACC, Hassum K, de Brito MB, et al. Histopathological evaluation of facial melasma treated with oral tranexamic acid alone and in combination with ketotifen. Anais Brasileiros de Dermatologia. 2026;101(3):501336. doi:10.1016/j.abd.2026.501336

BibTeX
@article{Cruz2026,
  author = {Cruz, Ana Clara Ladeira and Cassiano, Daniel Pinho and Miot, Hélio Amante and Espósito, Ana Cláudia Cavalcante and Hassum, Karime and de Brito, Mackerley Bleixuvehl and E Silva Enokihara, Milvia Maria Simões and Lima Constantino, Maria Carolina Cavalcanti and Bottura, Heitor Raia and de Almeida, Joaquim Soares and Bagatin, Ediléia},
  title = {Histopathological evaluation of facial melasma treated with oral tranexamic acid alone and in combination with ketotifen},
  journal = {Anais Brasileiros de Dermatologia},
  year = {2026},
  volume = {101},
  number = {3},
  pages = {501336},
  doi = {10.1016/j.abd.2026.501336}
}
Kostenlos starten →